Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles

Two series of five membered heterocyclic bis(1,3,4-oxadiazole) derivatives 2(a-h) and 3,5-bis(substituted)pyrazoles, isoxazoles 3(a,b,d-i), 4(a-c) were synthesized via oxidative cyclization of some diaroylhydrazones using chloramine-T and cyclocondensation reaction with hydrazine hydrate and hydroxylamine hydrochloride, respectively. The newly synthesized compounds were screened for antioxidant and anti-microbial activities. Compounds 2(b), 3(b), and 4(a) showed higher antioxidant activity at 10 μg/ml while compounds 2(a), 3(a), 3(f), and 4(a) exhibited better anti-microbial activity at 100 μg/ml compared with standard vitamin C and ciprofloxacin, respectively. Structures of newly synthesized compounds were confirmed by elemental analysis and spectral IR, ¹H NMR, and ¹³C NMR data.     

Structural studies of copper catalyzed hydroxylation reactions

The reaction of 2,6-diacetylpyridine, CuCl₂, and semicarbazide hydrochloride was studied as a function of pH to yield three different products: aqua(2-acetylsemicarbazone-3-hydroxo-6-acetylpyridine) chlorocopper(II) hemihydrate, 1, bis(2,6-diacetylpyridinedisemicarbazone)copper(I) chloride dimer, 2, and bis(2,6-diacetylpyridinedisemicarbazone)copper(II) chloride dimer, 3. The reaction of 1 with a mol of semicarbazide hydrochloride gave chloro(3-hydroxo-2,6-diacetylpyridinedisemicarbazone)copper(II) chloride hydrate, 4, and with a mol of semicarbazide hydrochloride and cupric chloride gave aquachlorocopper(II)(μ-chloro)(μ′-[2-acetylsemicarbazone-O,N-3-hydroxy-6-acetylsemicarbazonepyridine-O,N,N])aquacopper(II) trihydrate, 5. The crystal structures of compounds 1-5 were determined by X-ray diffraction. Some observations on the course of the reactions are given.     

Synthesis and biological evaluation of 4-styrylcoumarin derivatives as inhibitors of TNF-α and IL-6 with anti-tubercular activity

A series of 4-styrylcoumarin have been synthesized by Knoevenagel condensation between substituted 4-methylcoumarin-3-carbonitrile and different heterocyclic or aromatic aldehydes. 4-Methylcoumarin-3-carbonitrile has been synthesized by the base catalyzed reaction between substituted 2-hydroxyacetophenone and ethyl cyanoacetate. The structures of the newly synthesized compounds were confirmed by ¹H NMR, IR and mass spectral analysis. All the compounds were evaluated for their anti-inflammatory activity (against TNF-α and IL-6) and anti-tubercular activity. Compounds 6a, 6h and 6j exhibited promising activity against IL-6 with 72-87% inhibition and compound 6v showed potent activity against TNF-α with 73% inhibition at 10 μM concentration. Whereas compounds 6n, 6o, 6r and 6u showed very good anti-tubercular activity against Mycobacterium tuberculosis H37Rv strain at <6.25 μM.     

NF kappa B inhibitors and antitrypanosomal metabolites from endophytic fungus Penicillium sp. isolated from Limonium tubiflorum

Chemical investigation of the endophytic fungus Penicillium sp. isolated from Limonium tubiflorum growing in Egypt afforded four new compounds of polyketide origin, including two macrolides, penilactone (1) and 10,11-epoxycurvularin (2), a dianthrone, neobulgarone G (7), and a sulfinylcoumarin, sulfimarin (14), along with twelve known metabolites (3-6, 8-13, 15 and 16). The structures of all compounds were assigned by comprehensive spectral analysis (1D and 2D NMR) and mass spectrometry. Compounds 3, 4, 13 and 16 showed pronounced antitrypanosomal activity with mean MIC values ranging from 4.96 to 9.75 ??M. Moreover, when tested against a panel of three human tumor cell lines compounds 3, 4, 6 and 12 showed selective growth inhibition against Jurkat and U937 cell lines with IC₅₀ values ranging from 1.8 to 13.3 ??M. The latter compounds also inhibited TNF??-induced NF-??B activity in K562 cells with IC₅₀ values ranging from 1.6 to 10.1 ??M, respectively.     

Synthesis, characterization and electrochemistry of bis(3-aryl-6,6-dimethylcyclohexadienyl)ruthenium complexes

Five bis(3-aryl-6,6-dimethylcyclohexadienyl)ruthenium complexes (4a-4e) are prepared by reactions between di-μ-chlorodichlorobis[(1-3η:6-8η)-2,7-dimethyl-octadienyl]diruthenium and the corresponding dienes. The larger aryl substituents increase the barrier to rotation in 4a-4e relative to bis(3-methyl-6,6-cyclohexadienyl)ruthenium (5b). The activation parameters were determined by line-shape analysis for the exchange process in 4a: ΔG^† (183 K), 8.0 ± 0.2 kcal/mol; ΔH^†, 10.3 kcal/mol; and ΔS^†, 13 cal/mol/K. The electronic effect of the aryl substituents on the cyclohexadienyl ligand on the oxidation potential of the complex are compared to the effect of methyl substituents.     

Design and synthesis of 3-(azol-1-yl)phenylpropanes as microbicidal spermicides for prophylactic contraception

We designed a series of 25 3-(azol-1-yl)phenylpropanes which yielded 10 compounds (3, 4, 7, 8, 13, 14, 19, 21, 23, 26) that irreversibly immobilized 100% human sperm at 1% (w/v) concentration in 60 s; 12 compounds (8, 9, 15, 16, 19-21, 23-25, 27, 28) that showed potent microbicidal activity at 12.5-50 μg/mL against Trichomonas vaginalis; and 17 compounds (3-11, 13, 15, 19, 21, 23, 26, 28, 30) that exhibited potent anticandida activity with minimum inhibitory concentration (MIC) of 12.5-50 μg/mL. Almost all the compounds exhibited high level of safety towards normal vaginal flora (Lactobacillus) and human cervical (HeLa) cells in comparison to the marketed spermicide nonoxynol-9 (N-9). All the biological activities were evaluated in vitro. Two compounds (4, 8) with good safety profile exhibited multiple (spermicidal, antitrichomonas and anticandida) activities, warranting further lead optimization for furnishing a prophylactic vaginal contraceptive.     

Dinuclear terephthalato-bridged nickel(II) complexes. Structural characterization and magnetic properties

The dinuclear terephthalato-bridged nickel(II) complexes [Ni₂(cyclen)₂(μ-tp)](ClO₄)₂ (1) [Ni₂(trpn)₂(μ-tp)(H₂O)₂](ClO₄)₂ (2) and [Ni₂(3,3,3-tet)₂(μ-tp)(H₂O)₂](ClO₄)₂ · 2H₂O (3), where tp = terephthalate dianion, cyclen = 1,4,7,10-tetraazacyclododecane, trpn = tris(3-aminopropyl)amine and 3,3,3-tet = 1,5,9,13-tetraazatridecane, were synthesized and structurally characterized by X-ray crystallography. Their magnetic susceptibilities were also determined at variable temperatures over the range 2-300 K. The structures of these complexes consist of μ-tp bridging two Ni(II) centers in a bis(bidentate) bonding fashion in 1 and in bis(monodentate) bonding fashion in 2 and 3. The coordination geometry around the Ni(II) ions in these compounds has a distorted octahedral geometry with four nitrogen atoms from the amine ligand (cyclen, trpn or 3,3,3-tet) and two coordinated oxygen atoms supplied by the chelated carboxylate group of the bridged terephthalate ligand in 1, and by one tp-carboxylate-oxygen in 2 and 3. The sixth coordination site in the last two complexes 2 and 3 is achieved via an oxygen atom from a coordinated water molecule. The intradimer Ni…Ni distances in these complexes are 10.740, 11.428 and 11.537 Å for 1, 2 and 3, respectively. The electronic spectra of the complexes in aqueous solutions are in complete agreement with the assigned X-ray geometry around the Ni(II) centers. Also, the analysis of the infrared spectral data for the ν(COO⁻) stretching frequencies of the tp-carboxalato groups reveals the existence of the bis(bidentate) and bis(monodentate) coordination modes for the bridged terephthalate ligand in 1, 2 and 3, respectively. Despite the different coordination modes of the tp bridging ligand in these complexes, they all exhibit very weak antiferromagnetic coupling. The coupling constants J were found to be −2.2, −0.6 and −1.5 cm³ K mol⁻¹ for the complexes 1, 2 and 3, respectively. The structural and magnetic results of 1-3 are discussed in relation to the other related published μ-terephthalato dinuclear Ni(II) compounds.     

Structure–activity relationships of new 4-hydroxy bis-coumarins as radical scavengers and chain-breaking antioxidants

The main antioxidant properties of five new 4-hydroxy-bis-coumarins during bulk lipid autoxidation at 80 °C and 0.1 mM and 1.0 mM concentrations were studied and compared with 4-hydroxy-2H-chromen-2-one (1). These compounds are: 3,3′-((3,4-dihydroxy-phenyl) methylene) bis (4-hydroxy-2H-chromen-2-one) (2), 3,3′-((3,4-dimethoxyphenyl) methylene) bis (4-hydroxy-2H-chromen-2-one) (3), 3,3′-((4-hydroxy-3,5-dimethoxy-phenyl) methylene) bis(4-hydroxy-2H-chromen-2-one) (4) 3,3′-((3,4,5- trimethoxyphenyl) methylene) bis (4-hydroxy-2H-chromen-2-one) (5) 3,3′-((4-hydroxy-3-methoxy-5-nitrophenyl) methylene) bis (4-hydroxy-2H-chromen-2-one) (6), It was found that compound 2 with a catecholic structure in the aromatic nucleus showed the strongest antioxidant activity. Compound 4 showed a moderate antioxidant activity, and all the other compounds didn't show any capacity as chain-breaking antioxidants. Both 4-hydroxy-bis-coumarins (2 and 4) demonstrated also stronger radical scavenging activity towards DPPH radical by using TLC DPPH rapid test, than compound 1. The other compounds (3, 5, 6) didn't show any capacity as radical scavengers. The structure–activity relationship was discussed on the base of comparable kinetic analysis of studied 4-hydroxy-bis-coumarins with the known and standard antioxidants as α-tocopherol (TOH), caffeic acid (CA), sinapic acid (SA), ferulic acid (FA), and p-coumaric acid (p-CumA). In order to study the possible synergism between two phenolic antioxidants, the antioxidant efficiency and reactivity of two equimolar binary mixtures of coumarins and TOH (2 + TOH and 4 + TOH) and of corresponding cinnamic acid with TOH (CA + TOH and SA + TOH) were also tested and compared. The oxidation stability of the lipid substrate in presence of binary mixtures CA + TOH, SA + TOH and 2 + TOH appeared to be higher than that of the individual antioxidants. However, no synergism was obtained for all tested binary mixtures.     

Synthesis and antitumor activity of new d-seco and d-homo androstane derivatives

Starting from 3β-hydroxy-17-oxo-16,17-secoandrost-5-ene-16-nitrile (1), the new 16,17-secoandrostane derivatives 4-9 were synthesized. On the other hand, 3β-hydroxy-17-oxa-d-homoandrost-5-ene-16-one (10) yielded the new d-homo derivatives 12, 13 and 15. In vitro antiproliferative activity of selected compounds against three tumor cell lines (human breast adenocarcinoma ER+, MCF-7, human breast adenocarcinoma ER−, MDA-MB-231, prostate cancer AR−, PC-3, and normal fetal lung fibroblasts, MRC-5) was evaluated. Compounds 3 and 12 showed strong antiproliferative activity against PC-3 cells, the IC₅₀ values being 2 μM and 0.55 μM, respectively. Compounds 6 (10 μM) and 14 (9 μM) showed moderate activity against MDA-MB-231 cells. The synthesized compounds 1-3, 5-8, 10 and 12-15 were not toxic to normal fetal lung fibroblasts cells, MRC-5.     

The novel 3,4-dihydropyrimidin-2(1H)-one urea derivatives of N-aryl urea: synthesis, anti-inflammatory, antibacterial and antifungal activity evaluation

A series of novel 3,4-dihydropyrimidin-2(1H)-one urea derivatives of biological interest were prepared by sequential Bigineli’s reaction, reduction followed by reaction of resulting amines with different arylisocynates. All the synthesized (1-23) compounds were screened against the pro-inflammatory cytokines (TNF-α and IL-6) and antimicrobial activity (antibacterial and antifungal). Biological activity evaluation study reveled that among all the compounds screened, compounds 12 and 17 found to have promising anti-inflammatory activity (68-62% TNF-α and 92-86% IL-6 inhibitory activity at 10 μM). Interestingly compounds 3, 4, 5, 6, 15, 22 and 23 revealed promising antimicrobial activity at MIC of 10-30 μg/mL against selected pathogenic bacteria and fungi.     

Structures and luminescence of mononuclear and dinuclear base-stabilized gold(I) pyrazolate complexes

The mono- and dinuclear base-stabilized gold(I) pyrazolate complexes, (PPh₃)Au(μ-3,5-Ph₂pz)) (1), (TPA)Au(3,5-Ph₂pz), TPA=1,3,5-triaza-7-phophaadamantane (2), [(PPh₃)₂Au(μ-3,5-Ph₂pz)]NO₃ (3) and [(dppp)Au(μ-3,5-Ph₂pz)]NO₃, dppp=bis(diphenylphosphino)propane (4), have been synthesized and structurally characterized. The mononuclear gold(I) complexes 1 and 2 show intermolecular Au?Au interactions of 3.1540(6) and 3.092(6) Å, while the dinuclear gold(I) complexes 3 and 4 show an intramolecular Au?Au distances of 3.3519(7) and 3.109(2) Å, respectively, typical of an aurophilic attraction. Complexes 1-4 exhibit luminescence at 77 K when excited with ca. 333 nm UV light with an emission maximum at ca. 454 nm. The emission has been assigned to ligand-to-metal charge transfer, LMCT, based upon the vibronic structure that is observed.     

Chalcogenide-capped triruthenium clusters: X-ray structures of [Ru3(CO)6(μ3-CO){P(C4H3S)3}(μ-dppm)(μ3-O)] and [(μ-H)2Ru3(CO)6{P(C4H3S)3}(μ-dppm)(μ3-S)]

Treatment of [Ru₃(CO)₉{P(C₄H₃S)₃}(μ-dppm)] (1) [dppm = bis(diphenylphosphino)methane] with molecular oxygen in benzene at 60 °C affords oxo-capped [Ru₃(CO)₆(μ₃-CO){P(C₄H₃S)₃}(μ-dppm)(μ₃-O)] (2), while with elemental sulfur and selenium related chalcogenide-capped clusters [Ru₃(CO)₆(μ₃-CO){P(C₄H₃S)₃}(μ-dppm)(μ₃-E)] (3, E = S; 5, E = Se) and bis(chalcogenide) clusters [Ru₃(CO)₆{P(C₄H₃S)₃}(μ-dppm)(μ₃-E)₂] (4, E = S; 6, E = Se) result. Reaction of 1 with H₂S in refluxing THF affords the previously reported [(μ-H)₂Ru₃(CO)₇(μ-dppm)(μ₃-S)] (7) together with the new sulfido-capped dihydride [(μ-H)₂Ru₃(CO)₆{P(C₄H₃S)₃}(μ-dppm)(μ₃-S)] (8). All new compounds have been characterized by spectroscopic data, and 2 and 8 by single-crystal X-ray diffraction analyses. Oxo-capped 2 consists of a triangular ruthenium framework capped on opposite sides by oxo and carbonyl groups, while 8 consists of a ruthenium triangle by a capping sulfido ligand and two inequivalent bridging hydride ligands.     

Substituted imidazole derivatives as novel cardiovascular agents

A series of novel substituted imidazole derivatives were synthesized and have been screened in vivo for their hypotensive and acute toxicity activities. Out of seventeen compounds eight compounds (2b, 2c, 3b, 3c, 3f, 4a, 4b and 4c) have shown good hypotensive and bradycardiac responses. Compounds 3b, 3c, 3f and 4c have shown better activity than reference drug clonidine. All the compounds have shown ALD50 >1000 mg/kg with maximum in 2e and 4c (>1200 mg/kg).     

Synthesis, characterization and spectroscopy of alkyl substituted edge-bridged open ruthenocenes

The edge-bridged open ruthenocenes bis(η⁵-6,6-dimethylcyclohexadienyl)ruthenium (1), bis(η⁵-2,6,6-trimethylcyclohexadienyl) ruthenium (2), bis(η⁵-3,6,6-trimethylcyclohexadienyl)ruthenium (3), bis(η⁵-2,4,6,6-tetramethylcyclohexadienyl)ruthenium (4) are prepared by reactions between di-μ-chlorodichlorobis[(1-3η:6-8η)-2,7-dimethyloctadienyl] diruthenium and the corresponding dienes. Compound 4 can also be prepared in lower yield by reduction of RuCl₃ · nH₂O with zinc in the presence of 2,4,6,6-tetramethylcyclohexadiene. Variable temperature ¹H NMR studies of 1-4 reveal rapid rotation about the Ru-C bonds. The barrier to rotation in 4 is 7.7 kcal/mol with a gauche-eclipsed ground state conformation. Even lower barriers to rotation in 1-3 contribute to the inability to accurately measure their activation energies in toluene.     

New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease H

Two new monoterpene glycosides, distyloside A-B (1-2), and a new megastigmane glucoside, iso-dihydrodendranthemoside A (3) were isolated from twigs and leaves of Distylium racemosum, along with five known phenolic compounds (4-8). The structures were established via spectroscopic techniques and chemical transformations, and the absolute stereochemistry of 3 was determined by Mosher’s esterification. A homogeneous fluorescence resonance energy transfer (FRET) quenching assay was used to determine the inhibitory activity of isolates (1-8) on the ribonuclease H enzymes from HIV-1, 2, human, and Escherichia coli. Among them, 6″-O-galloylsalidroside (6) showed potent inhibitory effects with an IC₅₀ value of 3.5 μM on HIV-2, and 1.7 μM on human RNase H, respectively.     

Steroids from the leaves of Chinese Melia azedarach and their cytotoxic effects on human cancer cell lines

Three new (1-3) and several known (4-6) steroids were isolated from the leaves of Chinese Melia azedarach. The structures of the new compounds were elucidated by means of spectroscopic methods including 2D NMR techniques and mass spectrometry to be (20S)-5,24(28)-ergostadiene-3β,7α,16β,20-tetrol (1), (20S)-5-ergostene-3β,7α,16β,20-tetrol (2), and 2α,3β-dihydro-5-pregnen-16-one (3). The cytotoxicities of the isolated compounds against three human cancer cell lines (A549, H460, U251) were evaluated; only compounds 1, 2, and (20S)-5-stigmastene-3β,7α,20-triol (4) were found to show significant cyctotoxic effects with IC₅₀s from 12.0 to 30.1 μg/mL.     

Syntheses and characterization of titanium malonato and amino acid complexes: [Ti(cp)2(OOCCH2NMe2)] - The first structurally characterized α-amino acid titanium(III) complex

The reaction of [Ti(cp^∗)₂(BTMSA)] (1) (cp^∗ = η⁵-C₅Me₅, BTMSA = bis(trimethylsilyl)acetylene) with malonic acids ((HOOC)₂CR₂, R = H, Me) and N,N-dimethylglycine resulted in the formation of titanium(IV) dicarboxylato complexes [Ti(cp^∗)₂{(OOC)₂CR₂}] (R = H, 2; R = Me, 3) and an α-amino acid titanium(III) complex [Ti(cp^∗)₂(OOCCH₂NMe₂)] (4). The identities of complexes 2-4 were confirmed by microanalysis, ¹H and ¹³C NMR spectroscopy (2, 3), ESI-MS and CID experiments (2, 3) as well as by ESR and magnetic measurements (μ_eff = 1.81, 298 K) for 4. Single X-ray diffraction analyses of 2 and 4 exhibited monomolecular complexes in which the titanium atom is distorted tetrahedrally coordinated by two η⁵-C₅Me₅ rings and by the chelating bound malonato-κ²O,O′ (2) and N,N-dimethylglycinato-κ²O,O′ ligand (4).     

Regioselective one pot synthesis of 3,3'-diindolylethylene derivatives and study of their cytotoxic activity

2,2′-Diphenyl-3,3′-diindolylethylene (DPDIE) derivatives 3a-g were regioselectively prepared in one pot from indoles 1a-g in the presence of Lewis acids and were subsequently evaluated for cytotoxic activity against human leukemic cell lines, U937 and K562. The most potent compound 3g exhibited IC₅₀ of 13.0-17.0 μM.     

Design, synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl)fluoroquinolone derivatives

We report herein the design and synthesis of novel 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl) fluoroquinolone derivatives. The antibacterial activity of the newly synthesized compounds was evaluated and compared with gemifloxacin, levofloxacin and ciprofloxacin. Results reveal that compounds 10, 16, and 17 have good activity against all of the tested Gram-positive organisms including drug-resistance strains (MICs: 0.125-4 μg/mL). In addition, compounds 16 and 17 (MICs: 4 μg/mL) were 2- to 8-fold more potent than the reference drugs against Pseudomonas aeruginosa.     

Synthesis and evaluation of chromenyl barbiturates and thiobarbiturates as potential antitubercular agents

A novel series of barbiturate and thiobarbiturate analogs of 2-benzoyl-3-methyl-5-oxo-5H-furo[3,2-g]chromene-6-carbaldehydes (3a-g and 4a-d, respectively) and 6-methyl-4,8-dioxo-4,8-dihydropyrano[3,2-g]chromenes (7a-c), were synthesized and evaluated for their antitubercular activities against Mycobacterium tuberculosis H37RV, and cytotoxicity (CC₅₀) in the VERO cell MABA assay. The results indicate that the furanochromene series of compounds (3a-g and 4a-d) showed only weak to moderate antitubercular activity. However, the pyranochromene analog 7b showed good antitubercular activity (IC₉₀: 5.9 μg/mL) and cytotoxicity (CC₅₀: 14.27 μg/mL). The antitubercular activity of 7b was superior to the antituberculosis drug, pyrazinamide (PZA; IC₉₀: >20 μg/mL). Analog 7b was considered to be a lead compound for subsequent structural optimization.